Oppenheimer Reviews BioCryst Earnings By: Benzinga via Benzinga May 11, 2015 at 15:31 PM EDT In a report published Monday, Oppenheimer analysts maintained a Perform rating on BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), ... Read More >> Related Stocks: Biocryst Pharma Inc